Tempong, Jerome F.
HRN: 05-27-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/07/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/07/2024
03/20/2024
IVT
4.5g
Q8
Severe TBI; Multiple Soft Tissue Injuries Head And Extremities
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes